Results

Total Results: 1,108 records

Showing results for "percent".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/diagnostic-error-executive-summary.pdf
    August 01, 2023 - of serious misdiagnosis-related harms, and the top 15 conditions account for 68 percent. … When possible, to describe uncertainty, we present 95 percent confidence intervals (CIs); otherwise, … Together, they accounted for 68 percent (95% CI 66 to 71) of all serious harms from diagnostic error … (PR 0.1 to 0.7), and misdiagnosis-related deaths 0.2 percent (PR 0.1 to 0.4). … That just 5.7 percent of patients would be misdiagnosed, just 2.0 percent would suffer some sort of
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-pancreas_executive.pdf
    September 01, 2014 - 93 percent and summary specificity results ranging from 94 percent to 100 percent. … to 68 percent and specificities of 88 percent to 92 percent. … to 93 percent and specificity estimates ranging from 94 percent to 100 percent. … (95% CI, 76% to 85 percent) and a specificity estimate of 82 percent (95 percent CI, 77 percent to … specificity ranged from 82 percent to 97 percent.
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/asthma-provider-adherence_executive.pdf
    May 01, 2013 - to 34 percent in the pre-post design studies and ranged from 2 percent to17 percent in RCTs. … study, investigators observed a 12 percent increase (absolute change from 44 percent to 56 percent) … and control: 91 percent). … to 46 percent of providers, median 42 percent). … percent, 6 months: 81 percent) or hospitalizations (baseline: 96 percent, 6 months: 94 percent)
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-creating-efficiencies-extraction-data.pdf
    August 01, 2021 - sentences more than 80 percent of the time … precision and 91 percent recall. … percent (n = 15/75) used a no intervention control, and 12.0 percent used a wait-list control. … Seventy-nine percent (n = 124/157) of fragments for the funding source and 55.6 percent (n = 74/133) … More than 70 percent of solutions were at least partially relevant for an additional 19.0 percent (n
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-biopsy_surveillance.pdf
    July 01, 2012 - (95-percent CI: 18.0 to 32.1 percent). … (95-percent CI: 35.7 to 51.7 percent). … (95-percent CI: 81.2 to 99.4 percent). … (95-percent CI: 97.2 to 98.2 percent). … (95-percent CI: 95.8 to 98.9 percent).
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-drugs-utilization_research.pdf
    January 01, 2011 - While 83 percent of beneficiaries with erlotinib orders had a prior cancer diagnosis indicative of … Nearly all (98 percent) beneficiaries with Bacillus Calmette-Guerin (live) orders had a cancer diagnosis … before the order); alemtuzumab (88 percent); rituximab (84 percent); ibritumomab (70 percent); and … tositumomab (44 percent). … tissue, skin, and breast (170.x to 176.x) in 15 percent.
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-brain-injury_executive.pdf
    April 01, 2011 - 99 percent. … The BDI had poor sensitivity of 48 percent and 32 percent at specificities of 80 and 90 percent, respectively … The HADS provided 54 percent sensitivity and 76 percent specificity. … vs. 20.4 percent in one study; 60 percent vs. 7 percent in the second).59,125 The recruitment phase … vs. 7 percent: RR, 8.77; 95 percent CI, 5.56 to 13.83).
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-radiation_research.pdf
    November 01, 2012 - Meanwhile, use of CRT decreased from 24.1 percent to 12.7 percent. … percent in 2008; Table 3). … to 10.1 percent. … The proportion of HRRs with rates over 75 percent grew from 2006 to 2008 from 18.6 percent of HRRs … to 40.7 percent (Figure 1).
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/hypertension-drugs-utilization_research.pdf
    January 25, 2011 - percent) and in beneficiaries ages 65-74 (65.7 percent) and 75-84 (67.8 percent) compared with those … under 65 (48.1 percent) and 85+ (52.7 percent). … , 64.4 percent; Asian, 67.5 percent; Hispanic, 60.2 percent; Ameri- can Indian/Alaska Native, 54.7 percent … ; and other, 62.1 percent). … For example, in 2009, 88.7 percent of female beneficiaries with hypertension and 85.3 percent of male
  10. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-2007_executive.pdf
    January 01, 2007 - -39 years, 10 percent for adults aged 40-59 years, and 21 percent for adults aged 60 years or over. … to an elevated level of >6.5 to 7 percent (e.g., 10 percent). … : range 8-11 percent). … , 3.4 percent, and 3.2 percent, respectively; p < 0.05). … vs. 0.8 percent).
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-emergency_executive.pdf
    November 01, 2012 - (11 percent), and chest symptoms (9 percent). … percent (95% CI, 63 to 91 percent). … ) to 43 percent (95% CI, 16 to 75 percent). … ) to 48 percent (95% CI, 28 to 68 percent). … ) to 11 percent (95% CI, 0 to 22 percent).
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-medicare-use_research.pdf
    January 01, 2014 - Among Medicare beneficiaries with diabetes, approximately 14 percent had type 1, 85 percent had type … in 2007 to 14.2 percent in 2011 (Figure 4). … Overall, 84.8 percent of beneficiaries with type 1 diabetes and 83.9 percent of beneficiaries with … The frequency of cataract di- agnosis was comparable across all groups at 18.3 percent to 19.4 percent … of beneficiaries with type 1 diabetes, 54.4 percent of type 2 using insulin, and 50.9 percent of type
  13. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia_executive.pdf
    May 01, 2006 - treatment for solid tumors and 30-40 percent of patients treated for lymphoma. … to 100 percent in the studies reviewed. … However, trials varied widely in thromboembolic event rates: 0 percent to 30 percent among treated patients … and 0 percent to 23 percent among untreated patients. … , 63 percent, and 44 percent, respectively, were treated with erythropoietic stimulant.
  14. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-biopsy-executive.pdf
    December 01, 2009 - (95-percent confidence interval [CI]: 97.9 to 99.7 percent). … - percent CI: 95.8 to 98.9 percent). … to 92.1 percent). … , 5 percent, and 10 percent. … this probability would increase to 3 percent and 6 percent, respectively.
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/medicare-utilization-seniors_research.pdf
    June 01, 2012 - figure that jumped to 65 percent for those who en- rolled between 70 and 79, and 79 percent for those … , 27.6 percent of Asian/Pacific Islanders, 20.2 percent of Hispanics, 17.7 percent of American In- … dians/Alaska Natives, and 24.9 percent of persons classified as “other or unknown.” … Mortality for these new enrollees is very low at 0.4 percent. … While 98 percent of partial duals, 74 percent of nondu- als, and 67 percent of full duals have full
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/musculoskeletal-complaints-tests-children_executive.pdf
    March 01, 2012 - toxic synovitis (2.5 percent) and inflammatory arthritides (0.8 percent). … The Sn’s were 91 and 100 percent, and Sp’s were 84 and 85 percent (Table A). KQ 3.2. … The Sn was 29 percent, and Sp was 88 percent (Table A). KQ 3.4. … The Sn was 5 percent, and Sp was 98 percent (Table A). … It demonstrated a Sn of 5 percent and a Sp of 98 percent.
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-2007_research-2007-1.pdf
    January 01, 2007 - The rates of successful monotherapy ranged between 6 percent and 93.3 percent (median 61 percent). … groups (mean 6 percent, median 4 percent) and from 0 to 18 percent in ACEI-treated groups (mean 7 percent … , median 7 percent) and from 0 to 34 percent in ACEI-treated groups (mean 10 percent, median 7 percent … median 1 percent) and from 0 to 23 percent in ACEI-treated groups (mean 10 percent, median 9 percent … 3 percent) for patients on ARBs, and a mean of 19 percent for patients on ACEIs (median 8 percent).
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/undescended-testicle_executive.pdf
    December 01, 2012 - across the studies, compared with 42 to 92 percent for MRI and 60 percent in the one study on CT … accuracy and MRI 71.2-percent accuracy. … This study had a testicular descent rate of 63 percent for one-stage FS, 67.6 percent for two- stage … bPooled percent. … bPooled percent.
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/medicare-eligible-disabled_research.pdf
    June 01, 2011 - vs. 36 percent). … to 48 percent of African Ameri- cans, 44 percent of Asian/Pacific Island- ers, 44 percent of Hispanics … , 51 percent of American Indian/Alaska Natives, and 60 percent of those classified as “Other.” … and 1.69 percent (Table 2). … percent of full duals did so.
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/celiac-disease_clinician.pdf
    July 01, 2016 - The prevalence of celiac disease in the United States has been estimated at approximately 1 percent, … 5 percent have the HLA-DQ8 heterodimer. … ” if from 80.0 to 89.9 percent, and “excellent” if 90.0 percent or greater. … testing has a sensitivity of 89 percent (95% CI: 82.0% to 94.0%) and specificity of 98 percent (95% … In the other studies, the sensitivity of tTG and DGP was 57 to 96 percent in children and 29 to 85 percent

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: